Showing results (1271-1280 of 1,462) with videos related to

Sort By:
Pageof 147
Cancer & Metabolism|October 26, 2020
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibitionVictor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJohn H Sampson, Amy B Heimberger, Gary E Archer, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Genomics|February 9, 2000
Analysis of association at single nucleotide polymorphisms in the APOE regionE R Martin, J R Gilbert, E H Lai, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2016
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M Eby, Levi Barse, Steven W Henning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2017
Novel Targeting of Transcription and Metabolism in GlioblastomaYu-Ting Su, Robert Chen, Herui Wang, et al.
Human Molecular Genetics|April 18, 2015
Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesisRobert A Kozol, Holly N Cukier, Bing Zou, et al.
Frontiers in Oncology|February 6, 2023
Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature reviewStephen C Frederico, Elizabeth Vera, Zied Abdullaev, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Causes, Diagnostic Testing, and Treatments Related to Clinical Deterioration Events among High-Risk Ward PatientsMatthew M Churpek, Ryan Ingebritsen, Kyle A Carey, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphomaNadia N Laack, Brian Patrick O'Neill, Karla V Ballman, et al.
Pageof 147